ChemSpider 28536140
UNII 641H0Q518W YesY
Chemical and physical data
Formula C25H21F4N3O3
Molar mass 487.446 g/mol
3D model (Jmol) Interactive image

AZD5423 is a nonsteroidal glucocorticoid and phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.[1][2][3][4]

See also


This article is issued from Wikipedia - version of the 11/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.